{
  "name": "Alamar Biosciences, Inc.",
  "legal_name": "Alamar Biosciences, Inc.",
  "ticker": "ALMR",
  "tickers": [
    "ALMR"
  ],
  "cik": "0002104204",
  "page_url": "https://steadybase.io/company/alamar-biosciences-inc/",
  "markdown_url": "https://steadybase.io/company/alamar-biosciences-inc.md",
  "json_url": "https://steadybase.io/company/alamar-biosciences-inc.json",
  "as_of": "2026-11-10",
  "last_filed": "2026-11-04",
  "industry": {
    "sic": "3826",
    "description": "Laboratory Analytical Instruments"
  },
  "headquarters": {
    "city": "Fremont",
    "state": "CA",
    "country": "US"
  },
  "exchanges": [
    "Nasdaq"
  ],
  "fiscal_year_end": "December 31",
  "filer_category": "<br>Emerging growth company",
  "state_of_incorporation": "DE",
  "website": "alamarbio.com",
  "investor_relations_url": "https://alamarbio.com/company/investors/",
  "linkedin_company_url": "https://www.linkedin.com/company/alamar-biosciences-inc",
  "summary": {
    "text": "We are a commercial-stage proteomics company establishing a gold standard in protein detection and analysis. Our proprietary NULISA technology was purpose-built to address the limitations of existing proteomics tools by detecting protein biomarkers at extremely low concentrations in non-invasive biological fluids, such as blood, with ultra-high sensitivity, high specificity, flexible multiplexing, broad dynamic range and seamless automation.",
    "section": "Item 1. Business",
    "period_end": "2026-04-17",
    "source_url": "https://www.sec.gov/Archives/edgar/data/2104204/000119312526161647/d39680d424b4.htm"
  },
  "key_facts": [
    {
      "key": "shares_outstanding",
      "label": "Shares outstanding",
      "value": 69481651,
      "unit": "shares",
      "period_end": "2026-10-31",
      "form": "10-Q",
      "filed": "2026-11-04",
      "source_url": "https://www.sec.gov/Archives/edgar/data/2104204/000119312526445905/0001193125-26-445905-index.html",
      "text": "Shares outstanding: 69,481,651 as of Oct 31, 2026 (10-Q filed Nov 4, 2026)."
    }
  ],
  "metrics": {},
  "next_earnings": {
    "date": "2026-11-09",
    "confidence": "unconfirmed",
    "webcast_url": null
  },
  "people": [
    {
      "name": "Justin J. McAnear",
      "title": "Chief Financial Officer",
      "role": "officer",
      "linkedin_url": null,
      "form": "4",
      "filed": "2026-04-20",
      "source_url": "https://www.sec.gov/Archives/edgar/data/2104204/000178638626000006/0001786386-26-000006-index.htm"
    },
    {
      "name": "Shiping Chen",
      "title": "Chief Operating Officer",
      "role": "both",
      "linkedin_url": null,
      "form": "4",
      "filed": "2026-04-20",
      "source_url": "https://www.sec.gov/Archives/edgar/data/2104204/000212694426000004/0002126944-26-000004-index.htm"
    },
    {
      "name": "Timothy Ogden White",
      "title": "President",
      "role": "officer",
      "linkedin_url": null,
      "form": "4",
      "filed": "2026-04-20",
      "source_url": "https://www.sec.gov/Archives/edgar/data/2104204/000212670426000004/0002126704-26-000004-index.htm"
    },
    {
      "name": "Yuling Luo",
      "title": "PhD, founder, CEO, and chair of Alamar Biosciences",
      "role": "officer",
      "linkedin_url": "https://linkedin.com/in/yuling-luo-9216a5",
      "form": "8-K",
      "filed": "2026-11-03",
      "source_url": "https://www.sec.gov/Archives/edgar/data/2104204/000119312526445353/ck0002104204-ex99_1.htm"
    },
    {
      "name": "John L. Brottem",
      "title": "General Counsel",
      "role": "officer",
      "linkedin_url": "https://linkedin.com/in/john-brottem",
      "form": "4",
      "filed": "2026-09-16",
      "source_url": "https://www.sec.gov/Archives/edgar/data/2104204/000182338126000014/0001823381-26-000014-index.htm"
    }
  ],
  "events_8k": [
    {
      "filed": "2026-11-03",
      "items": [
        {
          "item": "2.02",
          "label": "Results of operations and financial condition (earnings release)",
          "signal": "earnings"
        },
        {
          "item": "5.02",
          "label": "Departure or appointment of directors or officers; compensation",
          "signal": "leadership_change"
        },
        {
          "item": "9.01",
          "label": "Financial statements and exhibits",
          "signal": "exhibits"
        }
      ],
      "source_url": "https://www.sec.gov/Archives/edgar/data/2104204/000119312526445353/ck0002104204-20261030.htm"
    },
    {
      "filed": "2026-09-01",
      "items": [
        {
          "item": "5.02",
          "label": "Departure or appointment of directors or officers; compensation",
          "signal": "leadership_change"
        }
      ],
      "source_url": "https://www.sec.gov/Archives/edgar/data/2104204/000119312526378360/d262303d8k.htm"
    },
    {
      "filed": "2026-08-10",
      "items": [
        {
          "item": "2.02",
          "label": "Results of operations and financial condition (earnings release)",
          "signal": "earnings"
        },
        {
          "item": "9.01",
          "label": "Financial statements and exhibits",
          "signal": "exhibits"
        }
      ],
      "source_url": "https://www.sec.gov/Archives/edgar/data/2104204/000119312526342378/ck0002104204-20260810.htm"
    },
    {
      "filed": "2026-07-15",
      "items": [
        {
          "item": "8.01",
          "label": "Other events",
          "signal": "other"
        }
      ],
      "source_url": "https://www.sec.gov/Archives/edgar/data/2104204/000119312526304736/d112405d8k.htm"
    },
    {
      "filed": "2026-05-08",
      "items": [
        {
          "item": "2.02",
          "label": "Results of operations and financial condition (earnings release)",
          "signal": "earnings"
        },
        {
          "item": "9.01",
          "label": "Financial statements and exhibits",
          "signal": "exhibits"
        }
      ],
      "source_url": "https://www.sec.gov/Archives/edgar/data/2104204/000119312526213379/ck0002104204-20260508.htm"
    },
    {
      "filed": "2026-04-20",
      "items": [
        {
          "item": "5.03",
          "label": "Amendments to articles or bylaws; change in fiscal year",
          "signal": "governance"
        },
        {
          "item": "8.01",
          "label": "Other events",
          "signal": "other"
        },
        {
          "item": "9.01",
          "label": "Financial statements and exhibits",
          "signal": "exhibits"
        }
      ],
      "source_url": "https://www.sec.gov/Archives/edgar/data/2104204/000119312526163921/d103481d8k.htm"
    }
  ],
  "insider_trades": [
    {
      "owner": "Nicholas Naclerio",
      "role": "Director",
      "action": "bought",
      "code": "P",
      "shares": 235294,
      "value_usd": 3999998,
      "date": "2026-04-20",
      "filed": "2026-04-20",
      "source_url": "https://www.sec.gov/Archives/edgar/data/2104204/000153416626000006/0001534166-26-000006-index.htm"
    }
  ],
  "quotes": [
    {
      "text": "Our third quarter results reflect continued strong demand for our platform, with revenue up 68% and biopharma customers accounting for the largest portion of our revenue for the first time",
      "speaker": "Yuling Luo",
      "title": "PhD, founder, CEO, and chair of Alamar Biosciences",
      "form": "8-K",
      "filed": "2026-11-03",
      "source_url": "https://www.sec.gov/Archives/edgar/data/2104204/000119312526445353/ck0002104204-ex99_1.htm"
    },
    {
      "text": "Tod has been an outstanding partner and leader during a pivotal period for Alamar",
      "speaker": "Yuling Luo",
      "title": "PhD, founder, CEO and chair of Alamar Biosciences",
      "form": "8-K",
      "filed": "2026-11-03",
      "source_url": "https://www.sec.gov/Archives/edgar/data/2104204/000119312526445353/ck0002104204-ex99_1.htm"
    }
  ],
  "latest_filings": [
    {
      "form": "8-K",
      "filed": "2026-11-03",
      "source_url": "https://www.sec.gov/Archives/edgar/data/2104204/000119312526445353/ck0002104204-20261030.htm"
    },
    {
      "form": "10-Q",
      "filed": "2026-08-11",
      "source_url": "https://www.sec.gov/Archives/edgar/data/2104204/000119312526343003/ck0002104204-20260630.htm"
    }
  ],
  "source": "SEC EDGAR filings, read by Steadybase. Every value links to the filing it came from."
}